142 related articles for article (PubMed ID: 12521509)
1. Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
Lehoczky O; Bagaméri A; Udvary J; Pulay T
J Obstet Gynaecol; 2002 May; 22(3):312-3. PubMed ID: 12521509
[No Abstract] [Full Text] [Related]
2. Emergency. Chemotherapy-induced hypersensitivity reaction.
Myers JS; Kearney K
Am J Nurs; 2000 Apr; 100(4):53-4. PubMed ID: 10776352
[No Abstract] [Full Text] [Related]
3. Single-dose dexamethasone paclitaxel premedication.
Micha JP; Rettenmaier MA; Dillman R; Fraser P; Birk C; Brown JV
Gynecol Oncol; 1998 May; 69(2):122-4. PubMed ID: 9600818
[TBL] [Abstract][Full Text] [Related]
4. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
[TBL] [Abstract][Full Text] [Related]
5. Taxol hypersensitivity: rapid retreatment is safe and cost effective.
Olson JK; Sood AK; Sorosky JI; Anderson B; Buller RE
Gynecol Oncol; 1998 Jan; 68(1):25-8. PubMed ID: 9454655
[TBL] [Abstract][Full Text] [Related]
6. [Taxol in the treatment of ovarian neoplasm].
Wang Y; Huang R; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
[No Abstract] [Full Text] [Related]
7. [Taxol].
Kühnle H
Zentralbl Gynakol; 1996; 118(10):580. PubMed ID: 8999717
[No Abstract] [Full Text] [Related]
8. Paclitaxel hypersensitivity revisited.
Essayan DM; Kagey-Sobotka A; Lichtenstein LM
J Clin Oncol; 1996 Mar; 14(3):1042. PubMed ID: 8622009
[No Abstract] [Full Text] [Related]
9. Paclitaxel-related hypersensitivity reactions and monitoring recommendations.
Myers JS
Clin J Oncol Nurs; 2002; 6(3):177-8. PubMed ID: 11998615
[No Abstract] [Full Text] [Related]
10. Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel.
Cormio G; Di Vagno G; Melilli GA; Cazzolla A; Di Gesù G; Carriero C; Cramarossa D; Loverro G; Selvaggi L
J Chemother; 1999 Oct; 11(5):407-9. PubMed ID: 10632389
[TBL] [Abstract][Full Text] [Related]
11. Elimination of frequent vital sign monitoring in patients receiving paclitaxel.
Thomas M
Oncol Nurs Forum; 1998 Jun; 25(5):828. PubMed ID: 9644696
[No Abstract] [Full Text] [Related]
12. Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions.
Bernstein BJ
Ann Pharmacother; 2000 Nov; 34(11):1332-5. PubMed ID: 11098349
[TBL] [Abstract][Full Text] [Related]
13. Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel.
Gennari A; Salvadori B; Tognoni A; Conte PF
Ann Oncol; 1996 Nov; 7(9):978-9. PubMed ID: 9006754
[No Abstract] [Full Text] [Related]
14. What you need to know about Taxol.
Lilley LL; Scott HB
Am J Nurs; 1993 Dec; 93(12):46-50. PubMed ID: 7905707
[No Abstract] [Full Text] [Related]
15. Paclitaxel in advanced ovarian cancer: too much optimism?
Bulusu VR; Allerton R
Gynecol Oncol; 1997 Aug; 66(2):335-6. PubMed ID: 9264587
[No Abstract] [Full Text] [Related]
16. Paclitaxel premedication regimens.
Boehm DK; Maksymiuk AW
J Natl Cancer Inst; 1996 Apr; 88(7):463-5. PubMed ID: 8618242
[No Abstract] [Full Text] [Related]
17. NICE approves Taxol for ovarian cancer.
Kmietowicz Z
BMJ; 2000 May; 320(7245):1293. PubMed ID: 10807610
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of ovarian and breast cancer with Taxol].
Dtsch Med Wochenschr; 1996 Dec; 121(50 Suppl):1-12. PubMed ID: 9022362
[No Abstract] [Full Text] [Related]
19. Paclitaxel hypersensitivity reactions related to bee-sting allergy.
Grosen E; Siitari E; Larrison E; Tiggelaar C; Roecker E
Lancet; 2000 Jan; 355(9200):288-9. PubMed ID: 10675081
[TBL] [Abstract][Full Text] [Related]
20. [Paclitaxel, a new anticancer drug].
Jekunen A; Lehtovirta P; Pyrhönen S
Duodecim; 1994; 110(13):1235-40. PubMed ID: 7497933
[No Abstract] [Full Text] [Related]
[Next] [New Search]
